AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Figures and large health care icons

Geisinger CMO works to cut friction and lift care

| 7 Min Read
Judge's gavel in movement with a virtual text

Don’t open door to more frivolous medical liability lawsuits

| 5 Min Read
Client at a spa appointment

36 states lack regulatory oversight of med spas

| 6 Min Read
Physician points at tablet

After the survey: Turning physician well-being results into change

| 15 Min Read